Sollazon

Medicinal product

(Invented) name

Sollazon

Active substance (s)

Cilostazolas

Strength

100 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AC23, Cilostazol

Marketing authorisation holder

Egis Pharmaceuticals PLC, Vengrija

Date of authorisation

2014-01-24

Date of renewal

2019-05-17

Documents

3495 Sollazon PL 2022 03 03.docx

3495 Pakuotės lapelis 2022 03 03.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

HU/H/0340/002/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Cilostazolas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
54811	68825	1068825	lizdinė plokštelė	N28		Receptinis	LT/1/14/3495/003	Netiekiama	-	-	No	-	-
58447	72611	1072611	lizdinė plokštelė	N56		Receptinis	LT/1/14/3495/004	Tiekiama	2025-03-24	-	No	-	-	Download
59856	74107	1074107	lizdinė plokštelė	N98		Receptinis	LT/1/14/3495/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-05-17	Perregistruotas
2014-01-24	Registruotas